Diabetes prevention

Xem 1-20 trên 78 kết quả Diabetes prevention
  • Diabetes-related cardiovascular complications often cause premature mortality, as well as disabilities such as blindness, foot ulceration and amputation. The health care and social care costs of managing these complications are enormous, but new treatments, devices and clinical management protocols are steadily improving the longer term outcomes for people with diabetes. This second edition has been revised and updated to reflect state of the art clinical practice.

    pdf228p crazy_sms 08-05-2012 48 21   Download

  • Reviews from previous editions: "A book that should find a place on the bookshelves of all physicians who care for diabetic patients." Hospital Update "I would thoroughly recommend that everyone read it if they do not wish to be left behind in this field." Journal of the Royal College of Physicians Diabetic foot problems are one of the most important long-term problems associated with diabetes. They can be a major cause of disablement and have serious economic consequences for health organisations.

    pdf365p crazy_sms 08-05-2012 55 20   Download

  • Diabetes mellitus is a common disease all over the world and its frequency is steadily increasing. The availability of a wide variety of treatment options results in improvement or even normalization of hyperglycemia as well as of the accompanying metabolic disorders. However people with diabetes continue to suffer from the complications of the disease. Diabetic foot-related problems occur frequently and may have serious consequences. Amputations at different anatomical levels are the most serious of them....

    pdf220p crazy_sms 07-05-2012 41 17   Download

  • Diabetes mellitus and its complications are clinical conditions of growing importance both from the clinical as well as epidemiological standpoint. The relevance of diabetes at clinical and individual level is given by its lifethreatening acute complications and, especially, by its chronic complications affecting several organs and systems, with increased risk for ocular, renal, cardiac, cerebral, nervous and peripheral vascular diseases.

    pdf264p ozon_ozon 03-05-2012 48 14   Download

  • It has been almost a decade since the first edition of Clinical Management of Diabetic Neuropathy was published. Since then, all societies have seen an explosion in obesity and diabetes. As a result, there is also an explosion in long-term diabetes complications, including diabetic neuropathy. Diabetic neuropathy therefore remains a major health problem that has not only serious consequences for the patient but also carries a significant financial burden for the health care-providing organizations of every society....

    pdf520p crazy_sms 07-05-2012 37 12   Download

  • We appear to be on the threshold of witnessing a substantial reduction in the longterm complications of diabetes. Modern treatment regimens, better monitoring of control and the huge impact of improved education all combine to offer the prospect of real progress towards prevention of complications and lessening of progression in those in whom complications may be present. The Diabetes Control and Complications Trial (DCCT) has provided eveidence that such can be achieved, while the St Vincent Declaration initiative has set the standards to enable these benefits to become reality....

    pdf260p crazy_sms 07-05-2012 38 11   Download

  • The fundamental treatment and management goals in diabetes mellitus are to control and normalize blood glucose levels and to prevent diabetic complications. It also includes maintaining normal growth and development and normal body weight. Proper diet, regular exercise, weight control and different therapeutic agents are the mainstays of diabetic care and management. Weight reduction and exercise have been shown to improve tissue sensitivity to insulin and allow its proper use by target tissues.

    pdf346p phoebe75 19-02-2013 28 10   Download

  • The prevalence of diabetes mellitus is growing at epidemic proportions in the United States and worldwide (1). Most alarming is the steady increase in type 2 diabetes, especially among young and obese persons. An estimated 7% of Americans are afflicted with diabetes, and with the longevity of this population increasing, the prevalence of diabetesrelated complications will continue to rise. Foot disorders are a major source of morbidity and a leading cause of hospitalization for persons with diabetes.

    pdf56p ozon_ozon 26-04-2012 47 10   Download

  • The underlying principle in managing diabetes has undergone several important changes over the last two decades. Diabetes was once believed to be a disease with inevitable microvascular and macrovascular complications. Current approaches to management, however, recognize the benefit of maintaining tight glycemic control and addressing associated metabolic disorders.

    pdf410p crazy_sms 08-05-2012 41 10   Download

  • As the global epidemic of diabetes continues to expand, the prevalence of type 2 diabetes is predicted to double in the next 20 years. Continued population growth, increasing age, and worldwide globalization leading to changes in diet and patterns of physical inactivity have resulted in staggering numbers of individuals affected by the disease. A haphazard approach to treatment for a problem of this magnitude could easily overburden the healthcare system, particularly in areas of the world with limited resources.

    pdf469p crazy_sms 08-05-2012 41 10   Download

  • Diabetes presents in many forms to different people in different fields. The person to whom it presents or the place in which it is diagnosed affects the initial assessment and management. The general practitioner is the central and constant figure in the patient’s care. Once you suspect the diagnosis of diabetes, confirm it, tell the patient the diagnosis, and explain what happens next.

    pdf235p crazy_sms 07-05-2012 32 9   Download

  • Diabetes mellitus is an important condition because it is common in developed countries, is becoming common in developing countries, and places a very great burden on individuals, healthcare systems and societies in all countries. In 1997 it was estimated that 124 million (2.1%) of the world's 5.8 billion total population had diabetes mellitus and it is projected that by 2010 this number will almost double to 221 million

    pdf248p crazy_sms 08-05-2012 24 7   Download

  • The U.S. Preventive Services Task Force (USPSTF) provides recommendations for evidence-based screening (Table 4-3). In addition to these population-based guidelines, it is reasonable to consider family and social history to identify individuals with special risk (www.ahrq.gov/clinic/uspstfix.htm). For example, when there is a significant family history of breast, colon, or prostate cancer, it is prudent to initiate screening about 10 years before the age when the youngest family member developed cancer.

    pdf5p tubreakdance 26-11-2010 42 6   Download

  • TRAITEMENT MEDICAMENTEUX DU DIABETE DE TYPE 2 (ACTUALISATION): AL’ordonnance n° 96-345 du 24 avril 1996 relative à la maîtrise médicalisée des dépenses de santé a confié à l’Agence française de sécurité sanitaire des produits de santé (Afssaps) la mission d’établir les références médicales et les recommandations de bonne pratique concernant le médicament. Elle stipule également que les références et recommandations de bonne pratique existantes doivent être régulièrement actualisées, en fonction des données nouvelles de la science.

    pdf158p 951864273 10-05-2012 54 6   Download

  • More than 19 million Americans have diabetes—a condition that can produce life-threatening complications. Of the two major forms of diabetes—type 1 and type 2—type 2 comprises 90 to 95 percent of all cases in the United States. An additional 13 million people have the precursor to type 2 diabetes, called prediabetes. Worldwide, type 2 diabetes affects more than 190 million people, and some experts predict that if the current trends continue that figure could surge to over 300 million by the year 2025....

    pdf289p hyperion75 22-01-2013 29 5   Download

  • Chapter 004. Screening and Prevention of Disease Examples include tests that are biochemical (e.g., cholesterol, glucose), physiologic (e.g., blood pressure, growth curves), radiologic (e.g., mammogram, bone densitometry), or tissue specimens (e.g., Pap smear, fine-needle aspirations). In the future, it is anticipated that genetic testing will play an increasingly important role for predicting disease risk (Chap. 64). However, such tests are not widely used except for individuals at risk for high-penetrance genes based on family or ethnic history (e.g., BRCA1, BRCA2).

    pdf25p socolanong 25-04-2012 29 4   Download

  • This report is based on research conducted by the Johns Hopkins University Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0018). The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

    pdf0p possibletb 29-11-2012 41 3   Download

  • For the 57th Nestlé Pediatric Nutrition Workshop, which took place in May 2005 at Half Moon Bay, San Francisco, the topic ‘Primary Prevention by Nutrition Intervention in Infancy and Childhood’ was chosen. Early nutrition seems to be involved in the mechanism of control, especially taking into account the role of protein and long-chain polyunsaturated fatty acids (LCPUFAs). It seems that the new generation of infant formulas already takes those findings into consideration. We would like to thank the two chairmen, Prof. Hugh Sampson and Prof.

    pdf289p cronus75 14-01-2013 47 2   Download

  • In the spring of 2010, the Centers for Disease Control and Prevention (CDC) and several partners embarked on an intensive process to examine the current state of knowledge regarding chronic obstructive pulmonary disease (COPD) prevention. he process included identifying public health gaps and generating a set of goals that would deine the unique role and contributions of public health in the prevention and control of COPD. his workgroup represented other federal agencies, academia, the health care sector, national organizations, and other COPD stakeholders.

    pdf20p quygia123 01-11-2012 16 0   Download

  • The nation faces a growing epidemic of childhood obesity that threatens the immediate health of our children and youth and their prospects of growing up to be healthy adults. During the past 30 years, obesity in the United States has more than doubled among children aged 2–5 years and adolescents aged 12–19 years, and it has more than tripled among children aged 6–11 years. Currently, more than 9 million children and youth over the age of 6 years are obese.

    pdf43p camchuong_1 10-12-2012 17 0   Download

CHỦ ĐỀ BẠN MUỐN TÌM

Đồng bộ tài khoản